Security key
07725L102
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 2,634,694
- Total 13F value
- $750,947,518
- Share change
- +73,308
- Put/Call ratio
- 102%
- SEC-reported price per share
- $284.97
- Number of holders
- 119
- Value change
- +$20,599,274
- Number of buys
- 69
- Number of sells
- 41
- Shares outstanding
- 1,448,910,175
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
119
Top holders
10
ONC full security history
Ownership snapshot
Full 13F holder table
BeOne Medicines Ltd. SEC filings
BeOne Medicines Ltd. company facts
BeOne Medicines Ltd. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
11 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 8%
13D/G row: BAKER BROS. ADVISORS LP
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
8%
HHLR ADVISORS, LTD.
4.9%
Capital International Investors
4.2%
Titus B. Ball
0.01%
Corazon (corsee) D. Sanders
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13D/G
3/4/5
13F
Julian C. Baker · Director · Company
|
8%
|
$36,692,201,272
115,912,814 shares
|
-$1,740,708 | 11 Jun 2026 |
| HHLR ADVISORS, LTD. |
3/4/5
13D/G
13F
10%+ Owner · Company
|
4.9%
from 13D/G
|
$25,009,148,200
125,045,741 shares
|
— | 02 Dec 2024 |
| Capital International Investors |
13F
13D/G
Company
|
4.2%
from 13D/G
|
$1,231,236,530
4,158,726 shares
|
— | 31 Mar 2026 |
| Titus B. Ball |
3/4/5
Principal Accounting Officer
|
0.01%
|
$29,591,575
99,645 shares
|
-$120,232 | 11 Jun 2026 |
| Corazon (corsee) D. Sanders |
3/4/5
Director
|
0%
|
$16,175,955
54,470 shares
|
-$1,859,272 | 22 May 2026 |
| Elizabeth Fisher Mooney |
3/4/5
Director
|
0%
|
$5,636,490
18,980 shares
|
— | 11 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
119
Shares
2,634,694
Rows available
119
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
282
Q2 2026 holders
119
Holder diff
-163
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|